Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by willibrichon Dec 07, 2010 4:09pm
488 Views
Post# 17814355

Trading patterns can tell you alot

Trading patterns can tell you alotabout a company and it's immediate prospects.

Yesterday our partner BWN traded 2,709,000 shares on 140 trades , for an average of  about 19300 shares per trade. Now this compares to BWN 's average trading volume of several hundred thousand shares at around 3000 shares per trade.

So yesterday there was bigger money chasing up the price on much larger volume.     Why ?
And why did BWN trade only 98,700 shares today , down 6 cents to .86  on 31 trades.........................thus resuming it's normal trading pattern of around 3000 shares per trade.
 
Meanwhile back at the ranch, QEI traded flat @ .20 yesterday on larger volume of 3.3 million shares.

And I see that TD and BMO Nesbitt are once again selling a ton of shares today . Twenty minutes ago, BMO Nesbitt tried to slam the price down to .185. Well it closed @ .19, down a penny   

QEI 's trading pattern is counterintuitive to what BWN is doing. I see no other reason for BWN 's action except the Colombia discovery well. And I 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
Bullboard Posts